M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with post-platinum esophageal adenocarcinoma (EAC): Preliminary results from a phase I cohort
Tan, B., Khattak, A., Felip, E., Kelly, K., Rich, P., Wang, D., Helwig, C., Dussault, I., Ojalvo, L., Isambert, N.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Assessment of PD-1/PD-L1 colocalization in hepatocellular carcinoma (HCC) using bright-field double labeling and quantitative digital image analysis
Mrowiec, T., Wilm, F., Frick-Krieger, E., Silva, M., Terracciano, L., Dussault, I., Ihling, C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype
Yoo, C., Oh, D.-Y., Choi, H.J., Kudo, M., Ueno, M., Kondo, S., Chen, L.-T., Osada, M., Helwig, C., Dussault, I., Ikeda, M.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial
Yoo, C., Oh, D.-Y., Choi, H.J., Kudo, M., Ueno, M., Kondo, S., Chen, L.-T., Osada, M., Helwig, C., Dussault, I., Ikeda, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Updated results from a phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated recurrent or refractory gastric cancer
Bang, Y.-J., Doi, T., Kondo, S., Chung, H.C., Muro, K., Dussault, I., Helwig, C., Osada, M., Kang, Y.-K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Updated results of M7824 (MSB0011359C): A bifunctional fusion protein targeting TGF-β and PD-L1, in second-line (2L) NSCLC
Paz-Ares, L., Kim, T.M., Vicente, D., Felip, E., Lee, D.H., Lee, K.H., Lin, C.-C., Oncala, M.J.F., Di Nicola, M., Alvarez, R.M., Dussault, I., Helwig, C., Ojalvo, L., Gulley, J., Cho, B.C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1931PAssessment of PD-1/PD-L1 colocalization in hepatocellular carcinoma (HCC) using bright-field double labeling and quantitative digital image analysis
Mrowiec, T, Wilm, F, Frick-Krieger, E, Silva, M, Terracciano, L, Dussault, I, Ihling, C
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
383TiP - Bintrafusp alfa (M7824) and eribulin mesylate in treating patients with metastatic triple negative breast cancer (TNBC)(NCT03579472)
Litton, J.K., Damodaran, S., Wistuba, I.I., Yang, F., Contreras, A., Tam, A., Ojalvo, L., Dussault, I., Helwig, C., Moulder, S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Bintrafusp alfa (M7824) and eribulin mesylate in treating patients with metastatic triple negative breast cancer (TNBC)(NCT03579472)
Litton, J.K., Damodaran, S., Wistuba, I.I., Yang, F., Contreras, A., Tam, A., Ojalvo, L., Dussault, I., Helwig, C., Moulder, S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
73P Long-term follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
Yoo, C., Oh, D-Y., Choi, H.J., Kudo, M., Ueno, M., Kondo, S., Chen, L-T., Osada, M., Helwig, C., Dussault, I., Ikeda, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Analysis of programmed death-ligand 1 (PD-L1) expression, transforming growth factor (TGF)-β gene expression signatures (GES) and tumor-infiltrating immune cells (IC) in hepatocellular carcinoma (HCC): Rationale for targeting PD-L1- and TGF-β
Zhang, Y., Naughton, B.J., Rolfe, P.A., Frick-Krieger, E., Dussault, I., Terracciano, L., Ihling, C.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
643PM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with post-platinum esophageal adenocarcinoma (EAC): Preliminary results from a phase I cohort
Tan, B, Khattak, A, Felip, E, Kelly, K, Rich, P, Wang, D, Helwig, C, Dussault, I, Ojalvo, L, Isambert, N
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
MO01.29 Randomized, Open-Label Study of Bintrafusp Alfa vs. Pembrolizumab as First-Line (1L) Treatment in Patients with PD-L1–Expressing Advanced Non-Small Cell Lung Cancer (NSCLC)
Ahn, M.-J., Barlesi, F., Felip, E., Garon, E., Martin, C.M., Vokes, E., Koenig, A., Dussault, I., Ojalvo, L.S., Paz-Ares, L.
Published in Journal of thoracic oncology (01.01.2021)
Published in Journal of thoracic oncology (01.01.2021)
Get full text
Journal Article
383TiPBintrafusp alfa (M7824) and eribulin mesylate in treating patients with metastatic triple negative breast cancer (TNBC)(NCT03579472)
Litton, J K, Damodaran, S, Wistuba, I I, Yang, F, Contreras, A, Tam, A, Ojalvo, L, Dussault, I, Helwig, C, Moulder, S
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
153OM7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): Efficacy by BTC subtype
Yoo, C, Oh, D-Y, Choi, H J, Kudo, M, Ueno, M, Kondo, S, Chen, L-T, Osada, M, Helwig, C, Dussault, I, Ikeda, M
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
757PM7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial
Yoo, C, Oh, D-Y, Choi, H J, Kudo, M, Ueno, M, Kondo, S, Chen, L-T, Osada, M, Helwig, C, Dussault, I, Ikeda, M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
661PUpdated results from a phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated recurrent or refractory gastric cancer
Bang, Y-J, Doi, T, Kondo, S, Chung, H C, Muro, K, Dussault, I, Helwig, C, Osada, M, Kang, Y-K
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P1.01-133 Randomized Open-Label Study of Bintrafusp Alfa (M7824) vs Pembrolizumab in Patients with PD-L1 Expressing Advanced 1L NSCLC
Ahn, M., Barlesi, F., Felip, E., Garon, E., Martin, C., Mok, T., Vokes, E., Ojalvo, L., Koenig, A., Dussault, I., Paz-Ares, L.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
1463PUpdated results of M7824 (MSB0011359C): A bifunctional fusion protein targeting TGF-β and PD-L1, in second-line (2L) NSCLC
Paz-Ares, L, Kim, T M, Vicente, D, Felip, E, Lee, D H, Lee, K H, Lin, C-C, Oncala, M J F, Di Nicola, M, Alvarez, R M, Dussault, I, Helwig, C, Ojalvo, L, Gulley, J, Cho, B C
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article